SomaLogic
Boulder, US · 2 known investors
SomaLogic provides high-throughput proteomics using its SOMAmer aptamer-based SomaScan platform, measuring thousands of proteins from small plasma samples through a CLIA-certified, CAP-accredited fee-for-service lab and a network of authorized sites. It serves academic medical centers, pharmaceutical, biotechnology, and contract research organizations across therapeutic areas including cardiovascular disease, neurology, oncology, diabetes, and rare disease.
BiotechDeep TechHealthtech
Founders & leadership
LG
Larry Gold PhDinFounder
CL
Charles LillisNamed on SEC filing
YY
Youichi YabuuchiNamed on SEC filing
TR
Terry RandallNamed on SEC filing
AR
Al ReynoldsNamed on SEC filing
DM
Daniel MuehlNamed on SEC filing
LG
Larry GoldNamed on SEC filing
BH
Byron HewettNamed on SEC filing
JM
Jessica MathewsNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$436.5M disclosed across 6 rounds · 2014–2020
▶$212MraisedJan 2021 · 33 investors · Other TechnologyRule 506(b)
▶$212MraisedJan 2021 · 33 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Roy SmytheExecutive Officer, Director
- Melody HarrisExecutive Officer
- Charles M. LillisDirector
- Anne MarguliesDirector
- Jessica MathewsDirector
- Franck MoisanDirector
- Richard PostDirector
- Eli CasdinDirector
- Offering amount
- $250M
- Amount sold
- $212M
- Sales commissions
- $11M
- Placement agents
- Cowen and Company LLC
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$969raisedOct 2018 · 1 investors · Other Technology
▶$969raisedOct 2018 · 1 investors · Other Technology
Officers, directors & promoters on the filing
- Larry GoldDirector
- Alister W. ReynoldsExecutive Officer, Director
- Takayuki ShiratsuchiDirector
- Jessica MathewsDirector
- Jun WangDirector
- Melody HarrisExecutive Officer
- Terry RandallDirector
- Charles LillisDirector
- Mark MessenbaughExecutive Officer
- Matthew NorkunasExecutive Officer
- Offering amount
- $969
- Amount sold
- $969
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 04
▶$147.2KraisedFeb 2018 · 1 investors · Other TechnologyRule 506(b)
▶$147.2KraisedFeb 2018 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Alister W. ReynoldsExecutive Officer, Director
- Matthew NorkunasExecutive Officer
- Takayuki ShiratsuchiDirector
- Terry RandallDirector
- Larry GoldDirector
- Steven H. MorrissettExecutive Officer
- Charles LillisDirector
- Jessica MathewsDirector
- Jun WangDirector
- Mark MessenbaughExecutive Officer
- Offering amount
- $147.2K
- Amount sold
- $147.2K
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$44.9MraisedJan 2018 · 3 investors · Other TechnologyRule 506(b)
▶$44.9MraisedJan 2018 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark MessenbaughExecutive Officer
- Takayuki ShiratsuchiDirector
- Matthew NorkunasExecutive Officer
- Jessica MathewsDirector
- Charles LillisDirector
- Terry RandallDirector
- Steven H. MorrissettExecutive Officer
- Larry GoldDirector
- Alister W. ReynoldsExecutive Officer, Director
- Jun WangDirector
- Offering amount
- $44.9M
- Amount sold
- $44.9M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$163MraisedJul 2017 · 17 investors · Other TechnologyRule 506(b)
▶$163MraisedJul 2017 · 17 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Steve MorrissettExecutive Officer
- Jessica MathewsDirector
- Takayuki ShiratsuchiDirector
- Larry GoldDirector, Promoter
- Charles LillisDirector
- Terry RandallDirector
- Teresa LipsceyExecutive Officer
- Mark MessenbaughExecutive Officer
- Matt NorkunasExecutive Officer
- Alister ReynoldsDirector
- Offering amount
- $163M
- Amount sold
- $163M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.5MraisedOct 2014 · 2 investors · Other TechnologyRule 506(b)
▶$16.5MraisedOct 2014 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Charles LillisDirector
- Youichi YabuuchiDirector
- Terry RandallDirector
- Al ReynoldsDirector
- Daniel MuehlExecutive Officer
- Larry GoldDirector
- Byron HewettExecutive Officer, Director
- Jessica MathewsDirector
- Offering amount
- $16.5M
- Amount sold
- $16.5M
- Minimum investment
- $1M
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Illumina (ILMN) Q2 2026 Earnings Call Transcript - AOLaol.com · Aug 2026Frequently asked questions
- What does SomaLogic do?
- SomaLogic provides high-throughput proteomics using its SOMAmer aptamer-based SomaScan platform, measuring thousands of proteins from small plasma samples through a CLIA-certified, CAP-accredited fee-for-service lab and a network of authorized sites. It serves academic medical centers, pharmaceutical, biotechnology, and contract research organizations across therapeutic areas including cardiovascular disease, neurology, oncology, diabetes, and rare disease.
- Who founded SomaLogic?
- SomaLogic was founded by Larry Gold PhD.
- Who are SomaLogic's investors?
- SomaLogic's investors include Foresite Capital, Khosla Ventures.
- How much funding has SomaLogic raised?
- SomaLogic has disclosed $436.5M raised across 6 rounds.
- Where is SomaLogic headquartered?
- SomaLogic is headquartered in Boulder, US.